Yabao Pharmaceutical Group Co., Ltd (SHA:600351)

Market Cap	4.26B
Revenue (ttm)	2.69B
Net Income (ttm)	242.69M
Shares Out	700.00M
EPS (ttm)	0.34
PE Ratio	20.21
Forward PE	n/a
Dividend	0.15 (2.46%)
Ex-Dividend Date	May 30, 2024

Volume	10,767,000
Average Volume	13,565,835
Open	6.03
Previous Close	6.04
Day's Range	6.03 - 6.14
52-Week Range	5.10 - 7.02
Beta	0.16
RSI	57.77
Earnings Date	Apr 26, 2025

About SHA:600351

Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. The company provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Yuncheng, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1978
• Employees: 4,142
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600351

Financial Performance

In 2024, SHA:600351's revenue was 2.69 billion, a decrease of -7.69% compared to the previous year's 2.91 billion. Earnings were 242.69 million, an increase of 21.60%.